Logo do repositório
 
Publicação

IMMUnity Unveiled

2025Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorGugu, Mitilda
dc.contributor.authorGugu, Mitilda
dc.contributor.authorAcharya, Shubhra
dc.contributor.authorAcharya, Shubhra
dc.contributor.authorPira, Dogukan
dc.contributor.authorPoletti, Simona
dc.contributor.authordi Flora, Alessia
dc.contributor.authorDi Flora, Alessia
dc.contributor.authorSaksida, Tamara
dc.contributor.authorSaksida, Tamara
dc.contributor.authorPilipenko, Vladimirs
dc.contributor.authorPilipenko, Vladimirs
dc.contributor.authorRomero-Ramos, Marina
dc.contributor.authorMarino, Franca
dc.contributor.authorMuñoz Delgado, Laura
dc.contributor.authorNikolovski, Neda
dc.contributor.authorGursoy Ozdemir, Yasemin
dc.contributor.authorLawson, Dale
dc.contributor.authorLawson, Dale
dc.contributor.authorComi, Cristoforo
dc.contributor.authorFigueira, Inês
dc.contributor.authorGürsoy-Ozdemir, Yasemin
dc.contributor.institutionNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
dc.contributor.pblEuropean Commission
dc.date.accessioned2025-02-19T21:22:49Z
dc.date.available2025-02-19T21:22:49Z
dc.date.issued2025
dc.descriptionPublisher Copyright: Copyright: © 2025 Gugu M et al.
dc.description.abstractParkinson’s disease (PD) affects more than one million people in the EU. It currently has no definitive cure, meaning that patients rely only on symptomatic treatments, which themselves are burdened by side effects. The need for advancements in both knowledge and available treatments is thus strongly felt by patients, caregivers, and health operators. This unmet need sparked the idea of orchestrating a collaborative effort via a common network – IMMUPARKNET (The role of IMMUnity in tackling PARKinson’s disease through a Translational NETwork). The IMMUPARKNET COST Action focuses on challenges in PD and its related crosstalk with immune response. Although widely recognized, the role of immunity in the onset and development of PD is still unclear. The main goal of IMMUPARKNET is to fill this knowledge gap by establishing an innovative, interdisciplinary research network and fostering exchanges of expertise among specialists from different countries and institutions. As we gather scientists and clinicians who study immunity in PD and related fields, IMMUPARKNET will establish the first nucleus of a multidisciplinary ecosystem that aims to harmonize efforts and approaches, both in research and clinical practice, to boost the development of ground-breaking treatments for PD. Through meetings, training schools, webinars, position papers, and review manuscripts, IMMUPARKNET will lead fruitful exchanges of know-how among experts in the field. The IMMUPARKNET structure revolves around 5 working groups, with a total of 157 active members from 34 different countries. Of these active members, 58.5% are young researchers, while 67.5% come from Inclusiveness Target Countries (ITC - less research-intensive COST Members; https://www.cost.eu/about/members/). IMMUPARKNET output will facilitate the improved sharing and development of research resources, straightening the road to novel treatments and identifying where existing ones can be repurposed, all, ultimately and hopefully, finding a cure for PD.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent2957642
dc.identifier.doi10.12688/openreseurope.17547.2
dc.identifier.issn2732-5121
dc.identifier.otherPURE: 110683986
dc.identifier.otherPURE UUID: 282320e1-3628-44c0-ae4a-0a9bb24016e8
dc.identifier.otherScopus: 85217444470
dc.identifier.urihttp://hdl.handle.net/10362/179393
dc.identifier.urlhttps://www.scopus.com/pages/publications/85217444470
dc.language.isoeng
dc.peerreviewedyes
dc.subjectimmune response
dc.subjectnetwork
dc.subjectParkinson's disease
dc.subjectGeneral
dc.titleIMMUnity Unveileden
dc.title.subtitleA Translational NETwork for tackling PARKinson's Disease – IMMUPARKNETen
dc.typejournal article
degois.publication.titleOpen Research Europe
degois.publication.volume4
dspace.entity.typePublication
person.familyNameGugu
person.familyNameAcharya
person.familyNamedi Flora
person.familyNameSaksida
person.familyNamePilipenko
person.familyNameLawson
person.familyNameGürsoy-Ozdemir
person.givenNameMitilda
person.givenNameShubhra
person.givenNameAlessia
person.givenNameTamara
person.givenNameVladimirs
person.givenNameDale
person.givenNameYasemin
person.identifier4409507
person.identifier1197281
person.identifier1879329
person.identifier.orcid0000-0002-5064-3915
person.identifier.orcid0000-0003-2904-6566
person.identifier.orcid0000-0003-4199-4307
person.identifier.orcid0000-0002-2527-3246
person.identifier.orcid0000-0002-7098-7483
person.identifier.orcid0009-0003-7837-1311
person.identifier.orcid0000-0002-0860-8964
person.identifier.ridE-7653-2015
person.identifier.scopus-author-id57425554200
person.identifier.scopus-author-id57224739314
person.identifier.scopus-author-id58661476000
person.identifier.scopus-author-id46061288700
person.identifier.scopus-author-id57188998170
person.identifier.scopus-author-id36546372200
rcaap.rightsopenAccess
relation.isAuthorOfPublication95d371af-6f7a-4884-af92-601609513a9e
relation.isAuthorOfPublication1c449505-f1ad-4b17-ab8c-88230a14a3cb
relation.isAuthorOfPublication46e7f801-5c5a-4c69-b10c-fca70fcc6cd8
relation.isAuthorOfPublicationf6dabdcc-4cc8-45e2-87ba-0e039ccb21ba
relation.isAuthorOfPublication622a5daa-14eb-441d-8564-1517ccd34ded
relation.isAuthorOfPublication278c879d-c4df-4df6-bd46-34706de2cec6
relation.isAuthorOfPublicationcec9c321-e698-4a85-887b-21ab6185de0b
relation.isAuthorOfPublication.latestForDiscoverycec9c321-e698-4a85-887b-21ab6185de0b

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
cd306e0b-8b31-4d66-98bb-51b75c88d3b9_17547_-_ines_figueira_v2.pdf
Tamanho:
2.82 MB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

NMS - Artigos em revista internacional com arbitragem científica